[1] YIN Y, LIU K J, LI G. Protective effect of prim-O-glucosylcimifugin on ulcerative colitis and its mechanism[J]. Front Pharmacol, 2022, 13:882924. [2] MARCHESI J R, ADAMS D H, FAVA F, et al. The gut microbiota and host health:a new clinical frontier[J]. Gut, 2016, 65(2):330-339. [3] SPADONI I, ZAGATO E, BERTOCCHI A, et al. A gut-vascular barrier controls the systemic dissemination of bacteria[J]. Science, 2015, 350(6262):830-834. [4] TOLSTANOVA G, KHOMENKO T, DENG X M, et al. Neutralizing anti-vascular endothelial growth factor (VEGF) antibody reduces severity of experimental ulcerative colitis in rats:direct evidence for the pathogenic role of VEGF[J]. J Pharmacol Exp Ther, 2009, 328(3):749-757. [5] LI X, HU Z H, SHI H R, et al. Inhibition of VEGFA increases the sensitivity of ovarian cancer cells to chemotherapy by suppressing VEGFA-mediated autophagy[J]. Onco Targets Ther, 2020, 13:8161-8171. [6] BOSMA E K, VAN NOORDEN C J F, SCHLINGEMANN R O, et al. The role of plasmalemma vesicle-associated protein in pathological breakdown of blood-brain and blood-retinal barriers:potential novel therapeutic target for cerebral edema and diabetic macular edema[J]. Fluids Barriers CNS, 2018, 15(1):24. [7] GAVARD J, GUTKIND J S. VEGF controls endothelial-cell permeability by promoting the β-arrestin-dependent endocytosis of VE-cadherin[J]. Nat Cell Biol, 2006, 8(11):1223-1234. [8] LI Y, YAO Y F, LI J, et al. Losartan protects against myocardial ischemia and reperfusion injury via vascular integrity preservation[J]. FASEB J, 2019, 33(7):8555-8564. [9] BODOR C, NAGY J P, VÉGH B, et al. Angiotensin Ⅱ increases the permeability and PV-1 expression of endothelial cells[J]. Am J Physiol Cell Physiol, 2012, 302(1):C267-C276. [10] SANO H, HOSOKAWA K, KIDOYA H, et al. Negative regulation of VEGF-induced vascular leakage by blockade of angiotensin Ⅱ type 1 receptor[J]. Arterioscler Thromb Vasc Biol, 2006, 26(12):2673-2680. [11] ALMUTLAQ M, ALAMRO A A, ALROQI F, et al. Classical and counter-regulatory renin-angiotensin system:potential key roles in COVID-19 pathophysiology[J]. CJC Open, 2021, 3(8):1060-1074. [12] SANTOS R A S, SAMPAIO W O, ALZAMORA A C, et al. The ACE2/angiotensin-(1-7)/MAS axis of the renin-angiotensin system:focus on angiotensin-(1-7)[J]. Physiol Rev, 2018, 98(1):505-553. [13] SALMENKARI H, KORPELA R, VAPAATALO H. Renin-angiotensin system in intestinal inflammation-Angiotensin inhibitors to treat inflammatory bowel diseases?[J]. Basic Clin Pharmacol Toxicol, 2021, 129(3):161-172. [14] JI X X, WANG H H, MA C, et al. Angiotensin converting enzyme 2 alleviates infectious bronchitis virus-induced cellular inflammation by suppressing IL-6/JAK2/STAT3 signaling pathway[J]. Chinese Journal of Biotechnology, 2023, 39(7):2669-2683. (in Chinese) 纪晓霞, 王换换, 马畅, 等. 血管紧张素转换酶2通过抑制IL-6/JAK2/STAT3信号通路抵抗传染性支气管炎病毒诱导细胞炎性反应[J]. 生物工程学报, 2023, 39(7):2669-2683. [15] BOURGONJE A R, ABDULLE A E, TIMENS W, et al. Angiotensin-converting enzyme 2(ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019(COVID-19)[J]. J Pathol, 2020, 251(3):228-248. [16] LEE K C, WU P S, LIN H C. Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis[J]. Clin Mol Hepatol, 2023, 29(1):77-98. [17] ZHANG J D, NOBLE N A, BORDER W A, et al. Infusion of angiotensin-(1-7) reduces glomerulosclerosis through counteracting angiotensin Ⅱ in experimental glomerulonephritis[J]. Am J Physiol Renal Physiol, 2010, 298(3):F579-F588. [18] MOREIRA F R C, DE OLIVEIRA T A, RAMOS N E, et al. The role of renin angiotensin system in the pathophysiology of rheumatoid arthritis[J]. Mol Biol Rep, 2021, 48(9):6619-6629. [19] GU S Z, XUE Y, WANG Y, et al. Comparison of the models of ulcerative colitis induced by three kind of concentration of dextran sulfate sodium in mice[J]. Modern Journal of Integrated Traditional Chinese and Western Medicine, 2019, 28(19):2053-2056, 2095. (in Chinese) 顾思臻, 薛艳, 王宇, 等. 3种浓度葡聚糖硫酸钠诱导小鼠溃疡性结肠炎模型的比较[J]. 现代中西医结合杂志, 2019, 28(19):2053-2056, 2095. [20] ALEX P, ZACHOS N C, NGUYEN T, et al. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis[J]. Inflamm Bowel Dis, 2009, 15(3):341-352. [21] SILVERBERG M S, CHO J H, RIOUX J D, et al. Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study[J]. Nat Genet, 2009, 41(2):216-220. [22] SUN Q Q, WU H M, LI S, et al. Regulation of inflammatory bowel disease by amino acids[J]. Chinese Journal of Biotechnology, 2022, 38(6):2128-2138. (in Chinese) 孙奇奇, 吴昊鸣, 李森, 等. 氨基酸对炎症性肠病的调控作用[J]. 生物工程学报, 2022, 38(6):2128-2138. [23] ZHOU W J, WU F M, YAO D S, et al. Production of high-purity recombinant human vascular endothelial growth factor (rhVEGF165) by Pichia pastoris[J]. Chinese Journal of Biotechnology, 2021, 37(11):4083-4094. (in Chinese) 周伟杰, 吴凤梅, 姚冬生, 等. 通过毕赤酵母表达系统获得高纯度的重组人血管内皮生长因子(rhVEGF165)[J]. 生物工程学报, 2021, 37(11):4083-4094. [24] GARG M, ROYCE S G, TIKELLIS C, et al. Imbalance of the renin-angiotensin system may contribute to inflammation and fibrosis in IBD:a novel therapeutic target?[J]. Gut, 2020, 69(5):841-851. [25] KHAJAH M A, FATEEL M M, ANANTHALAKSHMI K V, et al. Anti-inflammatory action of angiotensin 1-7 in experimental colitis[J]. PLoS One, 2016, 11(3):e0150861. [26] HE L, DU J, CHEN Y Y, et al. Renin-angiotensin system promotes colonic inflammation by inducing TH17 activation via JAK2/STAT pathway[J]. Am J Physiol Gastrointest Liver Physiol, 2019, 316(6):G774-G784. [27] KATADA K, YOSHIDA N, SUZUKI T, et al. Dextran sulfate sodium-induced acute colonic inflammation in angiotensin Ⅱ type 1a receptor deficient mice[J]. Inflamm Res, 2008, 57(2):84-91. [28] SPENCER A U, YANG H, HAXHIJA E Q, et al. Reduced severity of a mouse colitis model with angiotensin converting enzyme inhibition[J]. Dig Dis Sci, 2007, 52(4):1060-1070. [29] MIZUSHIMA T, SASAKI M, ANDO T, et al. Blockage of angiotensin Ⅱ type 1 receptor regulates TNF-α-induced MAdCAM-1 expression via inhibition of NF-κB translocation to the nucleus and ameliorates colitis[J]. Am J Physiol Gastrointest Liver Physiol, 2010, 298(2):G255-G266. [30] SHI Y Y, LIU T J, HE L, et al. Activation of the renin-angiotensin system promotes colitis development[J]. Scientific Reports, 2016, 6:27552. [31] GHEBLAWI M, WANG K M, VIVEIROS A, et al. Angiotensin-converting enzyme 2:SARS-CoV-2 receptor and regulator of the renin-angiotensin system:celebrating the 20th anniversary of the discovery of ACE2[J]. Circ Res, 2020, 126(10):1456-1474. |